Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 6;18(1):200.
doi: 10.1186/s12883-018-1203-4.

Plasma homocysteine levels and intracranial plaque characteristics: association and clinical relevance in ischemic stroke

Shan Shan Lu  1 , Jun Xie  1 , Chun Qiu Su  1 , Song Ge  2 , Hai Bin Shi  3 , Xun Ning Hong  4
Affiliations

Plasma homocysteine levels and intracranial plaque characteristics: association and clinical relevance in ischemic stroke

Shan Shan Lu et al. BMC Neurol. .

Abstract

Background: Elevated plasma homocysteine (Hcy) is an independent risk factor for ischemic stroke. This study aimed to evaluate the association between Hcy levels and intracranial plaque characteristics and to investigate their clinical relevance in ischemic stroke.

Methods: Ninety-four patients with intracranial atherosclerosis (ICAS) were enrolled. Plasma Hcy levels were measured. Intracranial plaque characteristics including plaque enhancement, stenosis ratio, T2 and T1 hyperintense components were assessed on high-resolution magnetic resonance imaging. Logistic regression model was constructed to analyze the association between high Hcy levels and plaque characteristics, and their synergistic effects to predict the likelihood for ischemic stroke, while adjusting for demographics and traditional atherosclerotic risk factors.

Results: Elevated Hcy level was associated with strong plaque enhancement independently of age, sex, serum creatinine levels and other atherosclerotic risk factors ((P < 0.001, OR 6.00, 95% confidence interval [CI] 2.28-15.74). Both strong plaque enhancement (P = 0.026, OR 5.63, 95% CI 1.23-25.81) and high Hcy level (P = 0.018, OR 6.20, 95% CI 1.36-28.26) were correlated with acute ischemic stroke. The combination of them strengthened the ability to stratify the likelihood for ischemic stroke, with an improved area under the receiver operating characteristic curve (AUC) of 0.871, significantly higher than that of strong plaque enhancement (0.755) and high Hcy level (0.715) alone (P < 0.05 for both).

Conclusions: High Hcy level appears to have association with intracranial strong plaque enhancement. The combined assessment of plasma Hcy levels and plaque enhancement may improve ischemic stroke risk stratification.

Keywords: Atherosclerosis; Homocysteine; Ischemic stroke; Magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was reviewed and approved by the institutional Review Board of the First Affiliated Hospital of Nanjing Medical University. The need for patient consent was waived by the same ethics committee.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
ROC curves for the ability of strong plaque enhancement and high homocysteine (Hcy) level to determine ischemic stroke. The AUC was 0.755 and 0.715 for strong plaque enhancement and high Hcy level, respectively. The combination of them after adjusting for sex, age, serum creatinine levels and other traditional atherosclerotic risk factors (hypertension, diabetes mellitus, hyperlipidemia, current smoker) in model 2 significantly improved the AUC to 0.871
See this image and copyright information in PMC

References

    1. Towfighi A, Saver JL. Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke. 2011;42:2351–2355. doi: 10.1161/STROKEAHA.111.621904. - DOI - PubMed
    1. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35–41. doi: 10.1161/01.STR.24.1.35. - DOI - PubMed
    1. Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12:1106–1114. doi: 10.1016/S1474-4422(13)70195-9. - DOI - PMC - PubMed
    1. Cao Y, Sun Y, Zhou B, Zhao H, Zhu Y, Xu J, et al. Atherosclerotic plaque burden of middle cerebral artery and extracranial carotid artery characterized by MRI in patients with acute ischemic stroke in China: association and clinical relevance. Neurol Res. 2017;39:344–350. doi: 10.1080/01616412.2017.1281196. - DOI - PubMed
    1. Bos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, Hofman A, et al. Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam study. JAMA Neurol. 2014;71:405–411. doi: 10.1001/jamaneurol.2013.6223. - DOI - PubMed